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Background: To determine the effect of flavonoids in conjunction with antibiotics in methicillin resistant
Staphylococcus aureus (MRSA) a study was designed. The flavonoids included Rutin, Morin, Qurecetin while
antibiotics included ampicillin, amoxicillin, cefixime, ceftriaxone, vancomycin, methicillin, cephradine, erythromycin,
imipenem, sulphamethoxazole/trimethoprim, ciprofloxacin and levolfloxacin. Test antibiotics were mostly found
resistant with only Imipenem and Erythromycin found to be sensitive against 100 MRSA clinical isolates and S.
aureus (ATCC 43300). The flavonoids were tested alone and also in different combinations with selected antibiotics.
Methods: Antibiotics and flavonoids sensitivity assays were carried using disk diffusion method. The combinations
found to be effective were sifted through MIC assays by broth macro dilution method. Exact MICs were determined
using an incremental increase approach. Fractional inhibitory concentration indices (FICI) were determined to
evaluate relationship between antibiotics and flavonoids is synergistic or additive. Potassium release was measured
to determine the effect of antibiotic-flavonoids combinations on the cytoplasmic membrane of test bacteria.
Results: Antibiotic and flavonoids screening assays indicated activity of flavanoids against test bacteria. The
inhibitory zones increased when test flavonoids were combined with antibiotics facing resistance. MICs of test
antibiotics and flavonoids reduced when they were combined. Quercetin was the most effective flavonoid (MIC
260 μg/ml) while morin + rutin + quercetin combination proved most efficient with MIC of 280 + 280 + 140 μg/ml.
Quercetin + morin + rutin with amoxicillin, ampicillin, cephradine, ceftriaxone, imipenem, and methicillin showed
synergism, while additive relationship was indicated between morin + rutin and amoxicillin, cephradine, ceftriaxone,
imipenem, and methicillin. Quercetin alone had an additive effect with ampicillin, cephradine, ceftriaxone, imipenem,
and methicillin. Potassium leakage was highest for morin + rutin + quercetin that improved further in combination with
imipenem. Morin and rutin alone had no activity but in combination showed activity against test bacteria.
Conclusions: The flavonoids when used in combination with antibiotics were found to increase each other activity
against test bacteria. The relationship between the flavonoids and antibiotics in most of the cases was additive. However
in a few cases synergism was also observed. Flavonoids alone or in combinations also damaged bacterial cell membrane.
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Plant secondary metabolites are characteristic of certain
plant species that occur as part of their normal metabolism
with little or no function in plant life cycle. These metabo-
lites may have bioactivities and also medicinal value like
anti-infective, antitumor, antithrombotic, and antihyperlipi-
demic [1]. Different species of genus Cipadessa, are used in
mitigation of rheumatism, malaria, dysentery, diabetes, and
haemorrhoids and as anti-venom in snake bites, with
active constituents including flavonoids, terpenoids,
tetranortriterpenoids, steroids and sesqueterpenoids
[2]. This is indicative that these metabolites may be a
common feature among different species of a genus,
showing common pharmacological effects in different
ailments. About 400 species of Saussurea genus, are
used as traditional medicines in China and Tibet in
problems related to menstruation, blood circulation,
fever and rheumatoid arthritis. The reason for their use in
these conditions is due to the presence of biologically
active compounds including flavonoids, terpenoids,
phytosterols, and phenolics. The antimicrobial activities in
these plant species have been related to flavanoids,
terpenoids and tannins [3]. Flavonoids are generally
present in photosynthesizing cells [4]. From ancient
times, preparations containing these compounds have
been used to treat human diseases. This class of natural
products is becoming the main target of research due to
their antimicrobial potentials.
Flavonoids have good antibacterial activities, like chrysin
that showed bacteriostatic activity against different Gram-
negative bacteria such as Escherichia coli and Pseudomonas
aeruginosa. Similarly, biacalien possess inhibitory effect on
S. aureus and on the growth of spore forming Bacillus
subtilis. Other flavonoids such as luteolin, lucenin,
apigenin, saponarin and vitexin were effective against
Gram-negative bacteria Enterobacter cloacae, Klebsiella
pneumonia, Proteus mirabilis, E. coli, P. aeruginosa, and
Proteus vulgaris [5]. An 126 interesting feature of these
flavonoids is their potentiating and synergistic behaviour
that is observed between active flavonoids as well as
combination of flavonoids with antimicrobial agents
[6]. Flavonoids like myricetin, datiscetin, kaempferol,
qurecetin and flavones like luteolin have inhibited
growth of MRSA and with myricetin were found effective
against VRE as well [7]. In another study alkyl gallates
(methyl, ethyl, propyl and butyl gallates) and gallic acid
with different classes of antibiotics such as β-lactams
(penicillin G, ampicillin, oxacillin, cephradine), quinolone
(norfloxacin), aminoglycosides (streptomycin, kanamycin,
vancomycin), chloramphenicol, arbekacin, fosfomycin and
tetracycline were used in combinations against drug
sensitive and resistant bacteria. It was observed that
these combinations had maximum inhibitory activity
in 90% clinical isolates at MIC of 15.6 μg/ml. However,combinations of β-lactams and alkyl gallates showed
synergestic activities against MRSA and MSSA [8].
Resistance to antimicrobial agents is a global issue
with methicillin resistant Staphylococcus aureus (MRSA) a
major concern [9]. In a study conducted in Pakistan
during 2005–2007, about 501 MRSA clinical isolates were
isolated from skin and soft tissue infections and were
tested for their susceptibilities against conventional antibi-
otics such as clindamycin, tetracyclines, cotrimoxazole
and rifampicin, chloramphenicol and fusidic acid. All of
these drugs were ineffective against MRSA isolates [10].
Difficulties in treatment of resistant microbes serve a
challenge to discover new drugs that can be effective
against these resistant bugs. Since plant metabolites are
not part of conventional therapy they can be considered
as monotherapy or in combination therapy against them.
Keeping in view the emerging threat of MRSA, present
study was designed to evaluate impact of selected flavo-
noids (morin, rutin, quercetin) alone and in combination
with conventionally used antibiotics for their activities
against S. aureus (ATCC 43300) and 100 MRSA clinical
isolates.Methods
Materials
The antibiotic discs included amoxicillin (AMO; 25 μg),
ampicillin (AMP; 10 μg), ceftriaxone (CET; 30 μg), cefixime
(CEF; 5 μg), cephradine (CEPH; 30 μg), erythromycin (ERY;
15 μg), vancomycin (VAN; 30 μg), methicillin (ME;
10 μg), ciprofloxacin (CIP; 5 μg), levolfloxacin (LEV;
5 μg), sulfamethaxozole-trimethoprim (S-T; 25 μg)
and imipenem (IMP; 10 μg) were from Oxoid, UK
while blank discs were purchased from Himedia, India. Test
flavonoids; rutin, morin, and quercetin were purchased
from Sigma-Aldrich, UK. Stock solutions of flavonoids
morin, rutin, and quercetin were made at concentrations of
50 g/l, 6 g/l, and 10 g/l respectively, using ethanol. Bacterial
culturing medias such as nutrient agar (NA; CM0003B),
muller hinton agar (MHA; CM0337B), nutrient broth (N.B;
CM0001B) and muller hinton broth (MHB; CM0405B)
were from Oxoid, UK. mannitol salt agar (MSA; LAB007)
was obtained from Lab M Limited, UK.Bacterial cultures collection, transport and processing
Clinical isolates (n = 300) were obtained from the micro-
biology laboratories of tertiary care hospitals which are
Hayatabad Medical complex, Lady Reading Hospital and
Khyber Teaching Hospital of Peshawar, KPK, Pakistan
while S. aureus (ATCC 43300, Rockville, USA) present
at PCSIR laboratories, was used as standard. Clinical
isolates were transported to Microbiology lab, PCSIR
Peshawar, Pakistan, for culturing, the same day within
2 hours after collection.
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agar (NA) plates and then incubated at 37 ± 1°C for
18 – 20 hours. Following incubation, plates showing
growth were subjected to Gram staining, catalase test,
coagulase test [11], and mannitol salt agar differentiation
[12]. The organisms showing yellow colonies on MSA
plates, gram-positive cocci in clusters, coagulase + ve, and
catalase + ve were considered S. aureus.
Isolated colonies of S. aureus from MSA plates were
aseptically inoculated in sterile nutrient broth and incu-
bated overnight at 37°C. Thereafter, turbidity of inoculum
was adjusted to 0.5 McFarland using 0.9% (w/v) sterile
normal saline and was used to prepare bacterial
lawns on sterile MHA plates. Methicillin discs were
applied on seeded plates and incubated overnight at
37 ± 1°C. Following incubation, plates with zones of
inhibitions <10 mm diameter or no zone of inhib-
ition were considered to be MRSA. The study was
approved by the Ethical Review Committee of Kohat
University of Science and Technology with a waiver
of informed consent.
Antibiotic sensitivity assays
Susceptibilities of clinical isolates and ATCC 43300 against
selected antibiotics, flavonoids and antibiotic + flavonoids
combinations were found using disc diffusion assay [13].
Flavonoids were tested alone, in different combinations,
and with test antibiotics at different concentrations as
shown in Table 1. Susceptibilities assays were carried
using sterile MHA plates. Following overnight incuba-
tion at 37°C zones of inhibitions were recorded. Test
substances were considered to have activity if zone of
inhibition was > 10 mm, while ≤ 10 mm zone of inhibition
were regarded as inactive.
Minimum inhibitory concentration (MIC) assays
MIC assays were carried out using broth macro-dilution
method. Different concentrations of flavonoids, their
combinations alone and with antibiotics were used.
Flavonoids and their combinations included morin + rutin
(M + R), quercetin (Q) and morin + rutin + quercetin
(M + R + Q). Test antibiotics with flavonoids alone and
their combinations included amoxicillin, ampicillin,
ceftriaxone, cephradine, imipenem and methicillin. Test
concentrations of flavonoids, flavonoid combinations alone
and with antibiotics are given in Table 2. The MICs of
these antibiotics against MRSA alone and in combinationTable 1 Flavonoids used in antibiotic sensitivity assays
Flavonoids Test concentrations used
Morin (M) 100 μg, 200 μg, 300 μg, 400 μg, 500 μg
Rutin (R) 100 μg, 200 μg, 300 μg, 400 μg, 500 μg
Quercetin (Q) 100 μg, 200 μg, 300 μgwith flavonoids were determined to confirm the synergistic
or additive effects. For the MIC’s assays stock solutions of
these antibiotics were prepared using sterile distilled water.
Exact MIC’s of flavonoids alone, in combinations and
with test antibiotics were determined by an incremental
increase approach in which higher concentrations were
obtained by the addition of 20 μg increments to the
lower concentrations. After test materials were trans-
ferred into sterile test tubes, bacterial cultures were
prepared as mentioned earlier. After inoculation and
addition of test materials tubes were incubated overnight
at 37°C. Absence of any visible growth in test tubes was
considered as the MIC of test material.
Fractional Inhibitory concentration (FIC) & FIC Index
To determine the effectiveness of test substances for
synergistic, antagonistic or additive effects FIC indices
were measured, using following formulas [14].
FIC of antibiotic (FICantibiotic) =MIC of antibiotic in
combination / MIC of antibiotic alone
FIC of flavonoid (FICflavonoid) =MIC of flavonoid in
combination / MIC of flavonoid alone
While FIC index was the sum of FIC of both antibiotic
and flavonoid.
FIC Index (FICI) = FICantibiotic + FICflavonoid
In case of two or more flavonoids used in combination
FIC was calculated in accordance to following formula [15].
FIC ¼ A=Mað Þ þ B=Mbð Þ
Where A and B are the MIC’s of these compounds in
combination while Ma and Mb are individual MICs of test
compounds. The test materials in their combinations
alone or with standard antibiotics were graded to
have synergistic (≤0.5), additive (>0.5 to 1), indifferent
(>1 to <2) or antagonistic (≥2) on the basis of FIC
indices [16].
Detection of cytoplasmic membrane damage
The assessment of the potassium present in medium
was carried out using flame photometer (PFP7, Jenway,
Sweden) at wavelength of 766.480 nm. Instrument was
calibrated using standard solutions containing 0.05, 0.1,
0.5, 1.0 and 5.0 μg/ml potassium chloride in ultra-pure
deionised water obtained from HACH water system USA.
Aliquots of 100 μl from each MRSA clinical isolate
and S. aureus (ATCC 43330) were separately incubated
overnight after incorporation of 1 ml previously sterilized
nutrient broth. The rise in the amount of potassium in
supernatant, caused by antibiotics, flavonoids, flavonoids-
antibiotics combination, in clinical isolates and control
Table 2 Test concentrations of flavonoids and their combination for MIC assays
Flavonoids Concentration ranges used for MIC assays (in μg/ml)
Broth half dilution method Incremental increase approach †
Maximum Minimum Maximum Minimum
Morin (M) NT* NT NT NT
Rutin(R) NT NT NT NT
Quercetin(Q) 600 75 300 180
Morin + Rutin(M + R) 800 + 800 100 + 100 500 + 500 380 + 380
Morin + Rutin + Quercetin (M + R + Q) 600 + 600 + 400 150 + 150 + 100 400 + 400 + 260 260 + 260 + 120
† To determine Exact MIC’s of test substances an incremental increase approach was adopted with 20 μg decrease in each dilution.
*Not tested.
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Results
Antibiotic sensitivity assays
Quercetin, M + R, and M +Q + R showed some activities
against MRSA clinical isolates and ATCC 43300. However,
morin, rutin and Q + R, Q +M combinations were found
inactive against test bacteria (Table 3). Quercetin and
active combinations were found to be more effective when
the antibiotics were combined with them. Antibiotics like
AMO, AMP, CEPH, CET, ME, S-T, and CEF that were
inactive when tested alone, expressed activity when
combined with Q, M + R and M+R +Q (Table 4).
However, test flavonoids were found to be having no
impact on VAN and ERY activity, while causing reduction
in CIP and LEV activities.
The concentration at which M + R showed activity
against the bacteria under study was 500 μg for each of
the flavonoid. The inhibition zones of this combination
observed at this concentration were 11.5 ± 0.22 mm
against standard bacteria and 11.58 ± 0.21 mm against
100 clinical isolates. Moreover, M + R was found to
increase activity of AMO, CEPH, IMP, CET and ME. CET
activity was increased highest, from 0 to 16.5 ± 0.30 mmTable 3 Average Zone of Inhibitions (in millimeters ±
STDEV) of Morin, Rutin, Quercetin, Morin + Rutin,
Quercetin + Rutin, Quercetin +Morin, and Morin +
Quercetin + Rutin against MRSA clinical isolates and
S. aureus (ATCC 43300)
Test flavonoid or
flavonoids combination
S. aureus MRSA clinical
isolates (n = 100)
M 0 0
R 0 0
Q 13.5 ± 0.21 13.33 ± 0.26
M + R 11.5 ± 0.22 11.58 ± 0.21
Q + R 0 0
Q +M 0 0
M + Q + R 16.5 ± 0.21 16.23 ± 0.26against standard and the zone of inhibition was increased
from 0 to 16.5 ± 0.29 mm, in comparison to all other test
antibiotics finding resistance against both standard strain
and clinical isolates. The zone of inhibition of vancomycin
and erythromycin were 18 ± 0.59 mm and 22 ± 1.36 mm
against ATCC 43300, which remained same in com-
bination with M + R. However, IMP activity enhanced
from 16 ± 0.90 mm to 19.5 ± 0.58 mm against ATCC
43300, while for clinical isolates it became 19.62 ± 0.31 mm
from 16.18 ± 0.92 mm in combination with M+R. The S-T
and AMP had no activity against test bacteria alone as
well as in combination with flavonoids. Ethanol, which
was used in making solutions of flavonoids, was having no
inhibitory activity.
Quercetin was found to be more active than M + R
combination. The average zones of inhibition of quercetin
against MRSA clinical isolates were 13.33 ± 0.26 mm while
it was 13.5 ± 0.21 mm in case of ATCC 43300. The results
revealed that quercetin alone possessed antibacterial
activity while morin and rutin have the same activity when
they were used in combination. It was also found to
increase the activity of antibiotics AMP, CEPH, CET and
ME that experienced resistance. Quercetin also had a
more blunting effect for CIP and LEV in comparison to
M+ R. It is evident from data presented in Table 4 that
among the antibiotics facing resistance, CET was most
responsive in combination with quercetin as zones of
inhibition enhanced from 0 to 20.5 ± 0.5 mm against
ATCC 43300 and 20.83 ± 0.45 mm in case of clinical
isolates, respectively. IMP was active against test MRSA
and its activity was further improved by quercetin from
16 ± 0.90 mm to 22 ± 1.10 mm against ATCC 43300 while
in case of clinical isolates it increased from 16.18 ± 0.92 mm
to 22.18 ± 1.12 mm. ERY and VAN activities remained
unchanged and resistance for S-T persisted even when it
was combined with quercetin.
As quercetin and M + R were found to have activities
against MRSA, they were combined together, and tested
in flavonoids combination as well as flavonoids-antibiotic
combinations against test bacteria. The results in the
Table 4 show that combined effect of flavonoids is greater
Table 4 Average zone of inhibitions (in mm± STDEV) of antibiotics alone and with flavonoid/(s) against S. aureus
(ATCC 43300) and MRSA clinical isolates (n =100)
Antibiotic alone M + R with antibiotic Q with antibiotic M + R + Q with antibiotic
AMO † 0 14.5 ± 0.29 13.5 ± 0.21 23.50 ± 1.1
AMO * 0 14.18 ± 0.36 13.33 ± 0.26 23.73 ± 1.1
AMP † 0 11.5 ± 0.22 17 ± 0.29 22.5 ± 1.2
AMP * 0 11.58 ± 0.21 17.33 ± 0.30 22.63 ± 1.2
CEPH† 0 14.5 ± 0.32 18.5 ± 0.31 24.55 ± 1.00
CEPH* 0 14.18 ± 0.29 18.33 ± 0.30 24.22 ± 1.00
CET † 0 16.5 ± 0.30 20.5 ± 1.00 27 ± 1.20
CET* 0 16.18 ± 0..29 20.83 ± 1.00 27.24 ± 1.23
IMP † 16 ± 0.90 19.5 ± 0.58 22 ± 1.10 28 ± 1.00
IMP* 16.18 ± 0.92 19.62 ± 0.31 22.18 ± 1.12 28.21 ± 0.90
ME † 0 13.5 ± 0.31 16.5 ± 0.28 21.5 ± 1.1
ME* 0 13.18 ± 39 16.89 ± 0.29 21.73 ± 1.0
VAN † 18 ± 0.59 18 ± 0.59 18 ± 0.59 18 ± 0.59
VAN* 17.37 ± 0.80 17.37 ± 0.80 17.37 ± 0.80 17.37 ± 0.80
LEV † 14 ± 0.91 9 ± 0.25 6.5 ± 0.21 3 ± 0.24
LEV* 13.88 ± 1.21 9.52 ± 0.25 6.85 ± 0.22 3.23 ± 0..25
CIP† 10.5 ± 2.5 7.24 ± 0.19 4 ± 0.22 2.25 ± 0.24
CIP* 13.1 ± 3.1 8.1 ± 0.18 4.35 ± 0.24 2.73 ± 0.21
ERY † 22 ± 1.36 22 ± 1.36 22 ± 1.36 22 ± 1.36
ERY* 20.96 ± 2.1 20.96 ± 1.10 20.96 ± 1.10 20.96 ± 1.1
S-T † 0 11.5 ± 0.22 13 ± 0.21 14 ± 0.21
S-T* 0 11.58 ± 0.21 13.33 ± 0.26 14.23 ± 0.26
CEF † 0 11.5 ± 0.22 13 ± 0.21 14 ± 0.21
CEF* 0 11.58 ± 0.21 13.33 ± 0.26 14.23 ± 0.26
† activity against S. aureus (ATCC 43300).
*activity against clinical isolates.
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these flavonoids (M + R +Q) against ATCC 43300 were
16.5 ± 0.21 mm and for clinical isolates 16.23 ± 0.26 mm,
which are greater than that of M + R (11.5 ± 0.22 mm for
ATCC 43300 & 11.58 ± 0.21 mm against clinical isolates)
and quercetin (13.33 ± 0.21 mm & 13.5 ± 0.26 mm)
respectively. It is evident from the results in Table 4 that
with triplet combination (M+ R +Q) the activity of both
AMP and AMO were increased. The inhibitory zones
observed in case of AMP and AMO with M+ R +Q were
22.5 ± 1.2 mm & 23.50 ± 1.1 mm against ATCC 43300.
While against clinical isolates zone of inhibition of AMO
in combination with M + R + Q was 23.73 ± 1.1 mm
which was greater than that observed for AMO
against the clinical isolates in combination with M + R
(14.18 ± 0.36 mm) and Q (13.33 ± 0.26 mm). Same trend
was also observed in case of AMP in combination with
M + R +Q, where inhibitory zones against the clinical
isolates were 22.63 ± 1.2 mm which were greater than
that observed for AMP when combined with M + Rand Q. M +R +Q showed no effect on the activity of VAN
and ERY as the zones of inhibition remained same. The
antagonistic effect of M + R + Q on CIP and LEV was
greater than that observed with M + R and Q alone.
M + R +Q had no effect on the activities of S-T and CEF.
MICs by serial half dilution method
Test flavonoids in combination or alone were quantified for
activities using serial broth half dilution method (Table 5).
The results for clinical isolates showed variation with 14
isolates giving MIC of 400 + 400 μg/ml for M+R while rest
of isolates (n = 86) were inhibited at 800 + 800 μg/ml con-
centrations. Similarly, for M+R +Q, 60 isolates gave MIC
of 200 + 300 + 300 μg/ml while remaining isolates (n = 40)
were inhibited at 200 + 600 + 600 μg/ml concentrations.
The MIC of quercetin determined by serial half dilution
method against the MRSA 43300 was 300 μg/ml and same
MIC was observed against 64 MRSA clinical isolates shown
in Table 5. While against remaining clinical isolates n = 36,
the MIC of quercetin was 600 μg/ml.
Table 5 MICs of flavonoid/(s) against S. aureus (ATCC
43300) and clinical isolates of MRSA
Flavonoids †MIC (μg/ml) *MIC (μg/ml)
M+ R 400 + 400 400 + 400 (n = 14)
800 + 800 (n = 86)
Q 300 300 (n = 64)
600 ( n = 36)
M + R+ Q 200 + 300 + 300 200 + 300 + 300 (n = 60)
200 + 600 + 600 (n = 40)
† activity against S. aureus (ATCC 43300).
*activity against clinical isolates.
Amin et al. BMC Complementary and Alternative Medicine  (2015) 15:59 Page 6 of 12Exact MICs of flavonoids and flavonoids-antibiotics by
incremental increase approach
Exact MICs of M + R, quercetin and M+ R +Q alone
and in combination with antibiotics were determined
against MRSA clinical isolates and ATCC 43300. The
MIC of M +R first determined by half dilution method is
given in Table 5. It is evident that MIC of each flavonoid
in combination was 400 μg/ml against standard strain
ATCC 43330. However, in case of clinical isolates MIC of
14 strains was 400 μg/ml while rest of 86 isolates gave
MIC value of 800 μg/ml. In order to arrive at exact MIC
for these strains an incremental increase approach was
adopted. The MIC data from this method is presented
in Table 6 for flavonoid and their combinations while
Table 7 gives exact MICs of flavonoids in combination
with test antibiotics.
Exact MIC for M + R was 400 μg/ml against ATCC
43300 while for clinical isolates (n = 100) average MIC
was 427.40 ± 14.40 μg/ml (Table 6). When combined
with amoxicillin (AMO) the MIC of M + R decreased to
340 μg/ml against ATCC 43300. This indicated that
there may be synergism or additive relationship between
the flavonoids and antibiotics experiencing resistance.
Similarly average MIC of M + R (427.40 ± 14.40 μg/ml)
was reduced to 367.40 ± 15.71 μg/ml when combined
with AMO. In case of CET the MIC of M + R against
ATCC 43300 was found to reduce from 400 μg/ml to
320 μg/ml while against the clinical isolates it decreased
from 427.40 ± 14.40 μg/ml to 347.40 ± 12.92 μg/ml. Similar
trend was also observed in case of other antibiotics. A
difference in the MIC’s of M+R and M+R+ antibiotic can
be seen in Tables 6 & 7. It is evident that reduction in MICs
of M+R is greater with IMP as it dropped from 400 μg/ml
to 300 μg/ml followed by CET, AMO and CEPH with
MICs reducing to 320 μg/ml, 340 μg/ml and 340 μg/ml
respectively against ATCC 43300. Same trend was also
observed with these antibiotics when tested against clinical
isolates. Methicillin was found to be less responsive than
other antibiotics. The reduction in MIC of flavonoids when
combined with antibiotics was an indication of their
increased activity against the bacteria under study.The MIC of quercetin determined by serial half
dilution method against ATCC 43300 was 300 μg/ml
and similar MIC was observed against 64 MRSA clinical
isolates (Table 6), while remaining clinical isolates (n = 36)
were inhibited at 600 μg/ml. Exact MIC of quercetin came
to be 260 μg/ml for ATCC 43300 and for clinical isolates
(n = 100) it varied between 260 – 300 μg/ml. Reduction in
MIC of quercetin in combination with antibiotics was
observed (Table 7) as it dropped from 260 μg/ml to
160 μg/ml when combined with AMP in case of MRSA
43300 whilst average MIC against clinical isolates reduced
from 284.64 ± 19.31 μg/ml to 184.64 ± 16.25 μg/ml.
Average MIC of Q with CEPH against clinical isolates
reduced to the same extent as for AMP. For ME the
decrease in the MIC was less than the other antibiotics.
Combinations of M + R +Q were tested to determine
the effectiveness against test bacteria. A clear reduction in
MICs was evident in comparison to their individual MICs.
The MIC of M + R +Q came to 300 + 300 + 200 μg/ml for
sixty clinical isolates while it was 600 + 600 + 200 μg/ml
for rest of forty isolates. Exact MIC of M + R +Q was also
determined (Table 6). It was observed that exact MIC of
Q in combination was 140 μg/ml and that of M + R
was 280 + 280 μg/ml against ATCC 43300 whilst in
case of clinical isolates (n = 100) Q had average MIC
163.56 ± 15.23 μg/ml while M + R had (303.56 ±
16.74 μg/ml) + (303.56 ± 16.74 μg/ml). It is evident
from data that in case of M + R + Q MICs of not only
rutin-morin reduced but quercetin’s MIC dropped as
well. The MIC of rutin-morin each was 400 μg/ml
but along with qurecetin it fell to 280 μg/ml against
ATCC 43300 whilst that of qurecetin reduced from
260 μg/ml to 140 μg/ml. Thus the antibacterial activity of
flavonoids was found to increase against MRSA when
used in combination with each other. Similarly the
incorporation of antibiotics with M + R + Q had an
enhancing effect on activities of test antibiotics. Data
in Table 7 suggests that MIC of this combination was
further reduced when combined with test antibiotics, i.e.,
with AMO, the MIC of rutin-morin and quercetin was
further reduced to 140 μg/ml (each) and 80 μg/ml against
ATCC 43300. The average MIC of rutin-morin with
AMO against the MRSA clinical isolates reduced to
163.56 ± 16.75 μg/ml from 367.40 ± 15.71 μg/ml but
quercetin had no effect on AMO activity. However in
M+R +Q with AMO, quercetin activity was increased as
its average MIC decreased to 103.56 ± 15.99 μg/ml from
284.64 ± 19.31 μg/ml against clinical isolates. The reduc-
tion in average MIC of M+R in M+R +Q combination
from 367.40 ± 15.71 to 148.31 ± 19.59 μg/ml with IMP
found greater than the rest of antibiotics against clinical
isolates. While a decrease in average MIC of quercetin in
M+R +Q combination, from 164.44 ± 17.11 μg/ml to
65.94 ± 16.9 μg/ml with CET was more than any other test
Table 6 Exact MICs (μg/ml) of flavonoid/(s) against S. aureus (ATCC 43300) and clinical isolates of MRSA
(M + R)♣ Q (M + R)♣ + Q
S. aureus (ATCC 43300) 400 260 (280)♣ + 140
Clinical Isolates 427.40a ± 14.40 279.00a ± 14.65 (303.56)♣ ±16.74 + 163.56a ±15.23
MIC Ranges 400 - 440 260 – 300 M + R = 280 – 340
Q = 140 – 200
♣=MIC’s of M & R are same in combination.
a= Average value.
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least activity with this flavonoid combination. Important
mention in this flavonoids combination is its enhancing
effect on both AMP and AMO, while the rest of the
flavonoids are either increasing AMO or AMP activity
but not both.
MIC’s of antibiotics alone as well as in combination
with flavonoids (Table 8) were determined in order to
prove that flavonoids decreased the MICs of antibiotics
thereby increasing their activity against MRSA. In com-
bination with flavonoids all antibiotics encountering re-
sistance became sensitive while maximum susceptibility
was conferred upon cell wall synthesis inhibitors. From
Table 8 it is evident that MIC of AMO was 256 μg/ml,
which reduced significantly to 64 μg/ml in combination
with M + R against ATCC 43300. The MIC of AMO inTable 7 Exact MICs (μg/ml) of flavonoid/(s) with antibiotics ag
MRSA
With (M + R)♣ W
AMO† 340 26
AMO* 367.40 ± 15.71 27
MIC range* 340 - 380 26
AMP† 400 16
AMP* 427.40a ± 14.40 17
MIC range* 400 - 440 16
CEPH† 340 16
CEPH* 367.40 ± 15.71 17
MIC range* 340 - 380 16
CET † 320 14
CET* 347.40 ± 12.92 15
MIC range* 320 - 360 14
IMP† 300 12
IMP* 327.80a ± 14.85 13
MIC range* 300 - 340 12
ME† 360 18
ME* 387.40 ± 15.78 19
MIC range* 360 - 400 18
♣MIC of M & R is same.
a= Average value.
*against MRSA clinical isolates (n = 100).
† against S. aureus (ATCC 43300).combination with M + R +Q decrease more significantly
than M + R from 256 μg/ml to 8 μg/ml. The observed
average MIC of AMO against clinical isolates (n = 100) was
197.70 ± 64.02 μg/ml that became 49.43 ± 16.03 μg/ml
when it was combined with M+R; and it reduced further
to 6.00 ± 2.13 μg/ml when used with M+R+Q. MIC of
AMP was 128 μg/ml against ATCC 43300 and its average
MIC value against clinical isolates was 162.85 ± 68.05 μg/ml.
However, no effect was observed in case of AMP when it
was combined with M+R. In combination with Q, MIC of
AMP dropped significantly from 128 μg/ml to 16 μg/ml.
The highest increase in activity was observed when AMP
was used in combination with M+R+Q, with MIC drop-
ping from 128 μg/ml to 4 μg/ml against ATCC 43300 while
its average MIC against clinical isolates (n = 100) reduced
from 162.85 ± 68.05 μg/ml to 5.09 ± 2.13 μg/ml.ainst S. aureus (ATCC 43300) and clinical isolates of
ith Q With (M + R)♣ + Q
0 (140)♣ + 80
9.00a ± 14.65 (163.56a)♣ ±16.75 + 103.56a ± (15.99)
0 - 320 M + R = 140 – 200; Q = 80 – 140
0 (160)♣ + 80
8.80a ± 14.25 (186.56a)♣ ± 15.80 + 112.37a ± 16.42
0 - 200 M + R = 160–220; Q = 80 – 140
0 (140)♣ + 60
8.80a ± 14.25 (163.56a)♣ ± 16.52 + 83.56a ±15.02
0 - 200 M + R = 140 – 200; Q = 60 – 120
0 (140)♣ +40
8.60a ± 15.11 (162.94a)♣ ± 16.98+ 65.94 a ± 16.9
0 - 180 M + R = 140 – 180; Q = 40 -100
0 (120)♣ +40
8.80a ± 14.99 (148.31a)♣ ± 19.59+ 66.56a ±16.50
0 - 160 M + R = 120–180 ; Q = 40 – 100
0 180 + 80
6.70a ± 12.75 (208.51a)♣ ± 19.98 + 88.51a ±19.80
0 - 220 M + R = 180 – 240; Q = 80-160
Table 8 Exact MICs (μg/ml) of antibiotics with flavonoid/(s) against S. aureus (ATCC 43300) and clinical isolates of MRSA
Antibiotic alone With M + R With Q With M + R + Q
AMO † 256 64♣ 256 8
AMO * 197.70a ± 64.02 49.43a ± 16.03 197.70a ± 64.02 6.00a ± 2.13
MIC range* 128 – 256 32 - 64 128 - 256 2-8
AMP † 128 128 16 4
AMP * 162.85a ± 68.05 162.85a ± 68.05 20.36a ± 8.51 5.09a ± 2.13
MIC range* 64 – 256 64 - 256 8-32 2-8
CEPH† 256 64 32 8
CEPH* 200.96 a ± 63.69 50.38 a ± 17.92 25.12a ± 7.92 6.28a ± 1.99
MIC range* 128 – 256 32 - 64 16 - 32 4-8
CET † 64 16 8 2
CET* 67.52 a ± 30.48 27.09 a ± 16.94 8.44a ± 3.81 2.11a ± 0.95
MIC range* 32 – 128 16 - 64 4 - 16 1-4
IMP † 32 8 4 1
IMP* 130.88 a ± 84.02 32.72 a ± 16.15 19.88a ± 10.51 4.97a ± 2.63
MIC range* 32 – 256 8 - 64 4 - 32 1-8
ME † 64 16 8 2
ME* 135.68 a ± 54.03 33.92 a ± 13.51 16.96a ± 6.75 4.24a ± 1.69
MIC range* 64 – 256 16 - 64 8 - 32 2-8
♣MIC of M & R is same.
a= Average value.
*against MRSA clinical isolates (n = 100).
† against S. aureus (ATCC 43300).
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inhibitory concentration index (FICI)
In order to term effect of antibiotics used in combination
with flavonoids as synergistic or additive FICI’s were
evaluated. The results (Table 9) showed an additive
response in case of quercetin and morin + rutin in
combination with test antibiotics such as amoxicillin,
Ampicillin, ceftriaxone, cephradine, imipenem and methi-
cillin. However, synergism was indicated when these
antibiotics were used in conjunction with M + R + Q.
Detection of cytoplasm membrane damage
The potassium leakage was measured for test bacteria with
flavonoids & antibiotics alone and flavonoids-antibiotics in
combination. From the data (Tables 10 and 11) it is appar-
ent that K+ leakage from flavonoid-antibiotic combination
was greater than the flavonoids and antibiotics alone. All
antibiotics and flavonoids induced release of K+ confirm-
ing damage they inflicted to bacterial cell membrane. K+
measured in case of AMO was 25.7 ppm for ATCC 43300
whilst for clinical isolates average K+ release was 25.79 ±
0.16 ppm. AMO’s K+ release in combination with M+R
was 32.3 ppm and 32.40 ± 0.13 ppm for ATCC 43300 and
clinical isolates, respectively. Highest leakage of potassium
was observed for IMP that was 26.6 ppm against ATCC
43300 and 26.79 ± 0.14 ppm for clinical isolates. The K+
leakage was further increased when IMP was used withflavonoids i.e. 36.6 ppm with M+R, 39.2 ppm with Q and
44.7 ppm with M+R +Q against ATCC 43300. The effect
became even more when M+R +Q was combined with
antibiotics (amoxicillin, Ampicillin, ceftriaxone, cephradine,
imipenem and methicillin), since K+ level from M+R+Q
was 32.7 ppm in case of ATCC 43300 while in case of iso-
lates average value of K+ leakage was 32.29 ± 0.13 ppm. K+
leakage for AMO in combination with M+R was
32.3 ppm, which increased to 41 ppm with M+R +Q in
case of ATCC 43300. Similar trend was observed in case of
other antibiotics.
Discussion
MRSA is now commonly isolated bug from nosocomial
infections and has potential to lead to fatalities. With
passage of time MRSA has also shown resistance to other
antibiotics as well such as tetracyclines, erythromycin and
genatmacin [17]. As a result of MDR (multidrug resistance)
the only choice left is vancomycin, which is also experien-
cing resistance and reports of emergence of vancomycin
intermediate S.aureus (VISA) and vancomycin resistant S.
aureus (VRSA) are there [17]. Therefore it is the need of
day to analyze MRSA and find new treatment modalities.
Morin and rutin alone have no antibacterial activity
but together they were active against S. aureus ATCC
25923 and E. coli ATCC 25922 [18]. Moreover, rutin has
been reported to enhance antibacterial activity of several
Table 9 Fractional Inhibitory Concentration indices (FICI)
of flavonoid/(s) and antibiotics against S. aureus (ATCC







isolates (n = 100)
Inference
M+ R + AMO 0.9 0.9 Additive
M + R + CEPH 0.9 0.95 Additive
M + R + CET 0.8 0.94 Additive
M + R + IMP 0.84 0.85 Additive
M + R +ME 0.95 0.97 Additive
Q + AMP 0.74 0.77 Additive
Q + CEPH 0.74 0.77 Additive
Q + CET 0.66 0.69 Additive
Q + IMP 0.66 0.69 Additive
Q +ME 0.82 0.83 Additive
M + R + Q + AMO 0.59 0.66 Additive
M + R + Q + AMP 0.59 0.68 Additive
M + R + Q + CEPH 0.46 0.50 Synergism
M + R + Q + CET 0.31 0.44 Synergism
M + R + Q + IMP 0.32 0.45 Synergism
M + R + Q +ME 0.45 0.5 Synergism
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other flavonoids such as morin and rutin against
Salmonella enteritidis and Bacillus cereus [15].Morin
was found active E. coli ATCC 25922, P. aeruginosa ATCC
27853 and S. aureus ATCC 29213 and respective clinical
isolates [20].
Quercetin activity has also been reported to increase
with oxacillin, vancomycin, gentamycin, and erythromycin
[21]. Quercetin is also found to increase the activity of
rifampicin and fusidic acid against MRSA 43300 and
clinical isolates [22]. Quercetin alone has been found
active against S. aureus and K. pneumoniae [23]. It has
also been found to be potentiating effects of antibiotics
such as rifampicin, fusidic acid and rifampicin against
MRSA and MSSA [24]. Quercetin alone and in combin-
ation with gentamycin, levolfloxacin and sulphadiazine
was found to be synergistic since MIC of qurecetin and
test antibiotics decreased four folds when they were
combined with each other [14]. Quercetin’s MIC ofTable 10 Potassium leakage (ppm) by flavonoid/(s) against
S. aureus (ATCC 43300) and clinical isolates of MRSA
Control Q M + R (M + R)♣ + Q
S. aureus
(ATCC 43300)
10.2 28.4 26.4 32.7
Clinical Isolates 10.19 ± 0.18 28.49 ± 0.14 26.49 ± 0.12 32.29 ± 0.13
♣MIC of M & R is same.260 μg/ml is comparable to previous report of 256 μg/ml
against MRSA [7]. It is evident from data (Table 4) that
among resistant antibiotics on which quercetin had
enhancing effect; CET was most responsive as increase in
the activity was greater than other antibiotics i.e. zones of
inhibition enhanced from 0 to 20.5 ± 0.5 mm in ATCC
43300. While in case of clinical isolates (n = 100) the
average zone of inhibition increased from 0 to 20.83 ±
0.45 mm. Those antibiotics including ERY, VAN and IMP
which were sensitive against ATCC 43300, among them
only IMP antibacterial activity increased as its inhibitory
zone rose from 16 ± 0.90 mm to 22 ± 1.10 mm in combin-
ation with quercetin. The S-T remained resistant even in
combination with quercetin. The results are consistent with
different reports in which it was used in combination with
antibiotics. Results can also be compared to the results
reported by Goyal et al., [25] where morin was used in
combination with quercetin against S. aureus, Salmonella
typhi, E. coli and B. subtilis. It was found that as a result of
using them in combination MICs of these flavonoids had
significantly decreased e.g. MIC’s of morin and quercetin
against S. aureus were 64 μg/ml and 32 μg/ml. But when
these flavonoids were combined MIC became 16 μg/ml
[15]. Morin and rutin alone had no activity against MRSA
but in combination showed antibacterial activity against
said bacteria. In similar studies flavonoids combinations
and their metallo-combinations show activity against
various microbes [26,27]. Morin alone has been found to
be active against Salmonella enteritidis with MIC of
150 μg/ml and B. cereus with MIC of 300 μg/ml. MICs
were further reduced when morin was combined with
rutin, i.e. MIC of morin with rutin lessened to 50 μg/ml
against S. enteritidis, while in case of B. cereus morin’s MIC
reduced to 100 μg/ml [15]. Morin also showed inhibitory
activity against S. typhi, E. coli, B. subtilis, and S. aureus
with MIC’s of 128 μg/ml, 128 μg/ml, 64 μg/ml and
64 μg/ml, respectively [25]. Morin when tested against
P. aeruginosa (ATCC 9027), S. epidermidis (ATCC 12228),
B. subtilis (ATCC 9372 & 6633) and E. coli (ATCC 8739 &
11775) inhibited the growth of all these bacteria [28]. In
another study the activity of morin and its complexes with
Gadolinium and Lutetium were tested against different
bacterial strains such as E. coli, K. pneumoniae , S. aureus;
results revealed morin complexes with Lu, and Gd, to be
more active than alone, thus suggesting potentiation by
these elements [29]. As evident from literature, morin
antibacterial activities enhance in combination with rutin,
therefore, this combination was tested against MRSA and
also with conventional antibiotics that are experiencing
resistance from this bug.
In present study combination of three flavonoids
enhanced their anti staphylococcal potential which is
evident from the MIC data. The MIC of M +R decreased
from 400 + 400 μg/ml to 280 + 280 μg/ml and that of Q
Table 11 Potassium leakage (ppm) by flavonoid/(s) with antibiotics against S. aureus (ATCC 43300) and clinical isolates
of MRSA
Test antibiotics Antibiotic alone Antibiotic +M + R Antibiotic + Q Antibiotic + M + R + Q
AMO † 25.7 32.3 NT 41
AMO * 25.79 ± 0.16 32.40 ± 0.13 NT 41.09 ± 0.11
AMP † 25.6 NT 34.4 39.6
AMP * 25.69 ± 0.13 NT 34.49 ± 0.14 39.83 ± 0.12
CEPH† 25.70 33.20 35.2 40
CEPH* 25.89 ± 0.14 33.30 ± 0.14 35.39 ± 0.14 40.10 ± 0.10
CET † 25.9 34.60 37.5 42.6
CET* 25.96 ± 0.10 34.69 ± 0.15 37.59 ± 0.10 42.69 ± 0.13
IMP † 26.6 36.6 39.2 44.7
IMP* 26.79 ± 0.14 36.79 ± 0.15 39.26 ± 0.14 45.89 ± 0.14
ME † 25.1 31.4 34.3 39.2
ME* 25.29 ± 0.12 31.52 ± 0.13 34.43 ± 0.11 39.33 ± 0.12
*against MRSA clinical isolates (n = 100).
† against S. aureus (ATCC 43300).
NT = Not tested.
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43300. In case of clinical isolates the M+ R average MICs
reduced from 427.40 ± 14.40 μg/ml to 303.56 ± 16.74 μg/ml.
While the average MIC of Q against the clinical isolates de-
creased from 279.00 ± 14.65 μg/ml to 163.56 ± 15.23 μg/ml.
It is in confirmation to the studies in which rutin, morin
and quercetin gave a synergistic response against S. aureu,
E.coli and Enterobacter aerogenes [7,19,30].
In present study MIC of CEPH was 256 μg/ml
against ATCC 43300 and its average MIC was 200.96 ±
63.69 μg/ml against clinical isolates. The MIC of CEPH in
combination with M+R decreased significantly to 64 μg/ml
against the ATCC 43300 and its average MIC against
clinical isolates decreased to 50.38 ± 17.92 μg/ml. The MIC
of CET was 64 μg/ml against ATCC 43300 that reduced to
16 μg/ml when it was combined with M+R. While in case
of clinical isolates average MIC of 67.52 ± 30.48 μg/ml for
CET was observed that reduced to 27.09 ± 16.94 μg/ml
when it was combined with M+R. Similarly, CET in com-
bination with Q and Q+M+R, against ATCC 43300 MIC
of 64 μg/ml dropped to 32 μg/ml and 8 μg/ml respectively
that are in confirmation to earlier reports [31,32].
The MIC of imipenem was 32 μg/ml against ATCC
43300 that reduced to 8 μg/ml when IMP was combined
with M+ R. While its average MIC against clinical isolates
was 130.88 ± 84.02 μg/ml. In combination with M +R
average MIC reduced to 32.82 ± 16.15 μg/ml. The MIC
range (32 - 256 μg/ml) of IMP against MRSA clinical
isolates found almost similar to that reported earlier [33].
In this study IMP tested alone and in combination
with catechins flavonoids (extracted from green tea
leaves) against MRSA clinical samples and standard
ATCC 25923. The MIC range found in this study was
16 – 256 μg/ml. In present study reduction in theimipenem’s MIC along with Q +M + R was found
greater than the other flavonoids. The MIC observed
against ATCC 43300 was 1 μg/ml and against the clinical
isolates it’s MIC range reduced from 32 - 256 μg/ml
to 1–8 μg/ml.
MIC of ME was 64 μg/ml against ATCC 43300 that
reduced to 16 μg/ml when it was combined with M + R,
this trend was also observed in case of clinical isolates
where average MIC decreased form 135.68 ± 54.03 μg/ml
to 33.92 ± 13.51 μg/ml. Effective concentrations of ME
were further reduced against the test bacteria when it was
combined with M + R + Q with MICs of 2 μg/ml and
4.24 ± 1.69 μg/ml for ATCC 43300 and clinical isolates
respectively.
The results also revealed that combined effects of
morin + rutin and quercetin in combination with the
antibiotics were additive (FICI <1). However, relationships
between quercetin +morin + rutin and CEPH, IMP, CET
and ME were synergistic (FICI ≤ 0.5). While Q +M+R
with AMP and AMO showed additive effect (FICI <1).
These results are in in conformity with earlier findings
where quercetin was found to be synergistic with
minocycline, fusidic acid and rifampicin [24].
Various compounds e.g. phenolics, have been known for
their ability to effect cytoplasmic membrane permeability
consequently resulting in leakage of cellular constituents
like nucleic acids, proteins and inorganic ions such as
phosphate and potassium [34]. Results of this study
suggest potassium leakage when flavonoids were used
alone, in combinations and with test antibiotics. Potassium
leakage data for Q (28.4 ppm), M + R (26.4 ppm), and
M + R +Q (32.7 ppm) against ATCC 43300 suggest
increase in extracellular K+ in comparison to control
(10.2 ppm). The highest K+ release was observed in
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results can be paralleled to that of galangin, a flavonol that
target cytoplasmic membrane of S. aureus and cause
potassium leakage [6].
Since the test concentrations used for antibiotics were
their MICs, therefore, K+ release was also observed in
the inoculums of test bacteria to which antibiotics were
added. The K+ release was increased when flavonoids
were used in conjunction to test antibiotics and highest
release was found in case of CET +M+ R (34.60 ppm &
34.69 ± 0.15 ppm), CET+Q (37.5 ppm & 37.59 ± 0.10 ppm),
CET+M+R+Q (42.6 ppm & 42.69 ± 0.13 ppm) against
ATCC 43300 and clinical isolates, respectively. Similarly,
IMP+M+R (36.6 ppm & 36.79 ± 0.15 ppm), IMP+Q
(39.2 ppm & 39.26 ± 0.14 ppm), IMP+M+R+Q (44.7 ppm
& 42.89 ± 0.14 ppm) against ATCC 43300 and clinical
isolates, respectively. Since both CET and IMP are bacter-
ial cell wall inhibitors, therefore, it can be hypothesized
that wall damage was implicated by test antibiotics
while cytoplasmic membrane injury was inflicted by flavo-
noids; with greater damage observed with combination of
flavonoids.
The present data suggests that antibiotics activity was
increased in combination with flavonoids. The flavonoids
used such as morin, rutin, and quercetin may also target
the cell wall of MRSA as evidenced from potassium
leakage data. Thus, combination of flavonoids with
antibiotics can be considered for therapeutic application
in case of microbes expressing resistance after safety
evaluations.
The present research was limited to in-vitro studies
only because of non-availability of animal models
facilities, which remained the major limitation of these
studies. Since the findings are promising, therefore, they
can be extended to in-vivo stage.
Conclusions
From the antibiotic sensitivity assays it is evident that
morin and rutin in combination were effective against
MRSA ATCC 43300 and its clinical isolates, while quer-
cetin alone found active against test bacteria. The activity
of flavonoids was further enhanced against ATCC 43300
and clinical isolates, when rutin, morin and quercetin
were used in combination. Test bacteria responded to
ampicillin, amoxicillin, cephradine, methicillin and ceftri-
axone when these antibiotics were mixed with flavonoids.
Similarly, imipenem activity was further increased against
test MRSA strains when combined with flavonoids.
Through MIC assays it was observed that both the flavo-
noids and antibiotics supplemented each other effects.
FICI results indicated an additive relationship between the
flavonoids and the antibiotics. While a synergistic effect
was also observed in M+R +Q-antibiotics combinations.
The cell wall synthesis inhibitors showed positive activityin conjunction to test flavonoids while activity of antibi-
otics affecting nucleic acid got blunted. Measurement of
potassium loss suggested cytoplasmic membrane damage
in conjunction with cell wall damage can be assumed to
be the mechanism of action of these flavonoids antibiotic
combinations. The sum of the substance of results was
that the activity of both flavonoids and antibiotics found
to increase when they were combined with each other.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MUA carried out the experimentation and drafting of manuscript. MK
contributed with conception and design of study, interpretation of data, and
manuscript preparation. BK and JK participated in data analysis and
interpretation. All authors read and approved the final manuscript.
Acknowledgements
Authors duly acknowledge the facilitation of Dr. Javed Ali, Mr. Zia-ur-Rehman
and the staff of Microbiology section, PCSIR, Peshawar, and Mr. Abdur Razzaq
from Sarhad University of Science & IT in in carrying out some experimentation.
Author details
1Department of Microbiology, Kohat University of Science and Technology,
Kohat, KP, Pakistan. 2Department of Pharmacy, Shaheed Benazir Bhutto
University, Sheringal, Dir Upper, KP, Pakistan.
Received: 2 September 2014 Accepted: 21 February 2015
References
1. Mazid M, Khan TA, Mohammad F. Role of secondary metabolites in defense
mechanisms of plants. Biol Med. 2011;3(2):232–49.
2. Bandi AK, Lee DU. Secondary metabolites of plants from the genus Cipadessa:
chemistry and biological activity. Chem Biodivers. 2012;9(8):1403–21.
3. Wang YF, Ni ZY, Dong M, Cong B, Shi QW, Gu YC, et al. Secondary
metabolites of plants from the genus Saussurea chemistry and biological
activity. Chem Biodivers. 2010;7(11):2623–59.
4. Cushnie TP, Lamb AJ. Detection of galangin-induced cytoplasmic
membrane damage in Staphylococcus aureus by measuring potassium loss.
J Ehanopharmacol. 2005;101:243–8.
5. Bylka W, Matlawska I, Pilewski NA. Natural flavonoids as antimicrobial
agents. J Am Nutraceutical Assoc. 2004;7(2):24–31.
6. Cushnie TP, Lamb AJ. Antimicrobial activity of flavonoids. Int J of Antimicrob
Agents. 2005;26:343–56.
7. Xu HX, Lee SF. Activity of plant flavonoids against antibiotic-resistant
bacteria. Phytother Res. 2001;15:39–43.
8. Shibata H, Kondo K, Katsuyama R, Kawazoe K, Sato Y, Murakami K, et al.
Alkyl gallates, intensifiers of beta lactam susceptibility in methicillin-resistant
Staphylococcus aureus. Antimicrob Agents Chemother. 2005;49:549–55.
9. Mutao CA, Jarnigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, et al.
SHEA guidelines for preventive Nosocomial transmission of multiresistant
strains of Staphlococcus aureus and Enterococcus. Infect Control Hosp
Epidemiol. 2004;24:362–8.
10. Idrees F, Jabeen K, Khan MS, Zafar A. Antimicrobial resistance profile of
Methicillin Resistant Staphylococcal Aureus from skin and soft tissue isolates.
J Pak Assoc. 2009;59(5):266–9.
11. Engelkirk PG, Duben-Engelkirk JL. Laboratory Diagnosis of Infectious
Diseases, Essential of Diagnostic Microbiology. In: Gram positive Cocci.
Philadelphia PA: Lippincott Williams & Wilkins; 2008. p. 215–9.
12. Bannerman TL. Staphylococcus, Micrococcus, and other catalase-positive
cocci that grow aerobically. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller
MA, Yolken RH, editors. Manual of clinical microbiology. 8th ed. Washington,
D.C: American Society for Microbiology Press; 2003.
13. Ergene A, Guler P, Tan S, Mirici S, Hamzaoglu E, Duran A. Antimicrobial and
antifungal activity of Heracleum sphondylium subsp. artivinense. Afr J Biotechnol.
2006;5(11):1087–9.
Amin et al. BMC Complementary and Alternative Medicine  (2015) 15:59 Page 12 of 1214. Sakharkar MK, Jayaraman P, Soe WM, Chow VTK, Sing LC, Sakharkar K. In
vitro combinations of antibiotics and phytochemicals against Pseudomonas
aeruginosa. J Microbiol Immunol Infect. 2009;42:364–70.
15. Arima H, Ashida H, Danno G. Rutin-enhanced antibacterial activities of
flavonoids against Bacillus cereus and Salmonella enteritidis. Biosci Biotechno
Biochem. 2002;66(5):1009–14.
16. European Committee on Antimicrobial Susceptibility Testing. Terminology
relating to methods for the determination of susceptibility of bacteria to
antimicrobial agents. EUCAST Definitive Document E. Def 1.2. Clini Microbiol
Infect. 2000;6:503–8.
17. Khan A, Faisal S, Hasnain S. The continuing threat of methicillin-resistant
staphylococcus aureus- past present future. J Scientific Res. 2010;40:37–45.
18. Alvarez MDLA, Debattista NB, Pappano NB. Synergism of flavonoids with
bacteriostatic action against Staphylococcus aureus ATCC 25 923 and
Escherichia coli ATCC 25 922. Biocell. 2006;30(1):39–42.
19. Lupaşcus D, Tuchiluş C, Profire L. Physico - chemical and antimicrobial
properties of novel rutin derivatives with 6-aminopenicillanic acid.
Farmacia. 2010;56(5):501–6.
20. Woènicka E, Kuèniar A, Nowak D, Nykiel E, Kopacz M, Gruszecka J, et al.
Comparative study on the antibacterial activity of some flavonoids and
their sulfonic derivatives. Pol Soc Pharm Drug Res. 2013;70(3):567–71.
21. Hirai I, Okuno M, Katsuma R, Arita N, Tachibana M, Yamamoto Y.
Characterisation of anti-Staphylococcus aureus activity of Quercetin. Int J
Food Sci Technol. 2010;45:1250–4.
22. Kyaw BM, Arora S, Win KN, Daniel LCS. Prevention of emergence of fusidic
acid and rifampicin resistance in Staphylococcus aureus using
phytochemicals. Afr J Microbiol Res. 2011;5(22):3684–92.
23. Xing ZC, Meng W, Yuan J, Moon S, JeongY KyuKang I. In vitro assessment of
antibacterial activity and cytocompatibility of quercetin-containing PLGA
nanofibrous scaffolds for tissue engineering. J Nanomaterials. 2012;2012:1–7.
24. Kyaw BM, Arora A, Lim CS. Bactericidal antibiotic-phytochemical combinations
against methicillin resistant Staphylococcus Aureus. Braz J of Microbiol.
2012;43(3):938–45.
25. Goyal P, Aggarwal BK, Garg S. A study on combinatorial effects of various
flavonoids for their antibacterial potential against clinically significant
bacterial species. Hacettepe J Biol Chem. 2010;38(4):255–8.
26. Hendra R, Ahmad S, Sukari A, Shukor MY, Oskoueian E. Flavonoid analysis
and antimicrobial activity of various parts of Phaleria macrocarpa (Scheff.)
Boerl fruit. Int J Mol Sci. 2011;12:3422–31.
27. Pereira AC, Oliveira DF, Geraldo H, Silva GH, Figueiredo HCP, Cavalheiro AJ.
Identification of the antimicrobial substances produced by Solanum
palinacanthum (Solanaceae). Ann Braz Academy Sci. 2008;80:427–32.
28. Rauha JP, Remes S, Heinonen M, Hopia A, Kaahkonen M, Kujala T, et al.
Antimicrobial effects of finnish plant extracts containing flavonoids and
other phenolic compounds. Int J Food Microbiol. 2003;56:3–12.
29. Kopacz M, Woènicka L, Gruszecka J. Antibacterial activity of morin and its
complexes with La(III), Gd(III) AND Lu(III) IONS. Pol Pharm Society.
2005;62(1):65–7.
30. Alvarez MA, Debattista NB, Pappano NB. Antimicrobial activity and synergism
of some substituted flavonoids. Folia Microbioligica. 2008;53(1):23–8.
31. Jones RN, Farrell DJ, Mendes RE, Sader HS. Comparative ceftaroline activity tested
against pathogens associated with community-acquired pneumonia: results from
an international surveillance study. J Antimicrob Chemother. 2011;66:69–80.
32. Odenholt I, Lowdin E, Cars O. In vitro pharmacodynamic studies of
L-749345 in comparison with imipenem and Ceftriaxone against gram
positive and gram negative bacteria. Antimicrob Agents Chemother.
1998;42(9):2365–70.
33. Aboulmagd E, Al-Mohammad HI, A-Badry S. Synergism and postantibiotic
effect of green tree extract and imipenem against methicillin-resistant
Staphylococcus sureus. Microbiol J. 2011;1(3):89–96.
34. Campos FM, Couto JA, Figueiredo AR, Tóth IV, Rangel AOSS, Hogg TA. Cell
membrane damage induced by phenolic acids on wine lactic acid bacteria.
Int J Microbiol. 2009;135(2):144–51.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
